Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prolactin Change and Its Effectors in Chinese Patients With Schizophrenia After Antipsychotics Treatment

NCT04002258 is registered in ClinicalTrials.gov with Shanghai Mental Health Center as lead sponsor.

NCT NCT04002258
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04002258 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prolactin Change and Its Effectors in Chinese Patients With Schizophrenia After Antipsychotics Treatment
Lead sponsor
Shanghai Mental Health Center
Phase
Observational
Overall status
Completed
Start date
June 6, 2019
Completion date
October 25, 2022
Enrollment
10,363 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antipyretics toxicity, prolactin excess, schizophrenia